Markus Zeitlinger
- Dose escalation study in healthy male subjects to investigate safety, tolerability and systemic exposure of orally inhaled single-doses of AP301By Helmut Pietschmann, Hendrik Fischer, Susan Tzotzos, Bernhard Fischer, Markus Zeitlinger, Rudolf Lucas, Robert Hermann and Hermann MascherHelmut Pietschmann1Clinical Research and Development, APEPTICO Forschung & Entwicklung, Vienna, AustriaHendrik Fischer1Clinical Research and Development, APEPTICO Forschung & Entwicklung, Vienna, AustriaSusan Tzotzos1Clinical Research and Development, APEPTICO Forschung & Entwicklung, Vienna, AustriaBernhard Fischer1Clinical Research and Development, APEPTICO Forschung & Entwicklung, Vienna, AustriaMarkus Zeitlinger2Department of Clinical Pharmacology, Medical University of Vienna, AustriaRudolf Lucas3Vascular Biology Center, Georgia Health Sciences University, Augusta, United StatesRobert Hermann4cr.appliance, Radolfzell, GermanyHermann Mascher5Pharm-Analyt Labor, Baden/Wien, Austria
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.